Conference Coverage

MS and (non-COVID) vaccinations: consensus recommendations


 

From ECTRIMS 2021

Which vaccines?

On which vaccines are needed in patients with MS, the consensus document recommends the same routine vaccination schedule as for the general population. In addition, it advises influenza and pneumococcal vaccination if patients are immunosuppressed or have significant disability.

It also recommends human papillomavirus vaccine in women and men independent of their age if they are to be treated with alemtuzumab, fingolimod, cladribine, or anti-CD20 drugs. Hepatitis B vaccination is also advised in patients treated with anti-CD20 drugs.

Special populations: pregnancy/elderly

In patients with MS who are pregnant, inactivated flu vaccine can be given in any trimester at the start of the flu season, and vaccination against diphtheria, tetanus, and pertussis can be given during the third trimester, the report says. Live attenuated vaccines should be completed at least 1 month before pregnancy or after delivery and 4-6 weeks prior to the initiation of immunosuppressive therapy.

Elderly patients with MS should receive flu and pneumococcal vaccines annually and would also benefit from the inactivated herpes zoster vaccine.

Travel vaccines

On vaccinations needed for travel, the report recommends that patients with MS consult a specialized travel clinic or vaccination expert and start immunizations 2-3 months before departure. Patients with MS with or without immunosuppressive therapy can receive hepatitis A, rabies, Japanese encephalitis, tic-borne encephalitis, polio, and inactivated typhoid vaccine. But yellow fever and oral typhoid are contraindicated in patients on immunosuppressive therapies.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

MRI is a poor disability predictor in secondary progressive MS
ICYMI Multiple Sclerosis
MS plus depression can increase risk of death, vascular disease
ICYMI Multiple Sclerosis
COVID-19 vaccination in MS: Lower response on certain medications
ICYMI Multiple Sclerosis
Melatonin improves sleep in MS
ICYMI Multiple Sclerosis
Cortical lesions predict risk for secondary progressive MS
ICYMI Multiple Sclerosis
In MS, baseline cortical lesions predict cognitive decline
ICYMI Multiple Sclerosis
Ublituximab improves functional MS score: New ULTIMATE analysis
ICYMI Multiple Sclerosis
The Barcelona baseline risk score may predict long-term MS course
ICYMI Multiple Sclerosis
ECTRIMS/EAN statement on COVID-19 vaccination in patients with MS
ICYMI Multiple Sclerosis
Rituximab more effective than other MS treatments?
ICYMI Multiple Sclerosis